Maureen Hillenmeyer
Co-founder and Chief Executive Officer · Hexagon Bio · Menlo Park, CA, United States
Biotechnology · Series C · Founded 2016
Latest raise
$62M
Date raised
October 23, 2026
Round
Series C
About Maureen Hillenmeyer
a biopharmaceutical company pioneering the discovery of novel payload mechanisms for antibody-drug conjugates (ADCs)
- Who is Maureen Hillenmeyer?
- Maureen Hillenmeyer is listed as Co-founder and Chief Executive Officer of Hexagon Bio, a biotechnology company founded in 2016 based in Menlo Park, CA, United States.
- How much did Hexagon Bio raise?
- Hexagon Bio raised $62M in a Series C round on October 23, 2026 (10 days ago). Backed by The Column Group.
Get newly funded founders every week
A free weekly list of startups that just raised.